𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Surgical Strategy for Cystic Diseases of the Liver in a Western Hepatobiliary Center

✍ Scribed by Basil J. Ammori; Benjamin L. Jenkins; Phillip C.M. Lim; K. Rajendra Prasad; Stephen G. Pollard; J. Peter A. Lodge

Publisher
Springer
Year
2002
Tongue
English
Weight
654 KB
Volume
26
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A two-year prospective study of the effe
A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis–associated liver disease
✍ Anders Lindblad; Hans Glaumann; Birgitta Strandvik πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 284 KB πŸ‘ 1 views

The efficacy of 2 years of treatment with ursodeoxycholic acid (UDCA) in cystic fibrosis (CF)-associated liver disease was evaluated by liver biopsies and liver function tests in 10 patients aged 8 to 28 years. The metabolism of UDCA was investigated by analysis of urinary bile acids with fast atom

A systematic review of the performance o
A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation
✍ Evangelos Cholongitas; Laura Marelli; Vibhakorn Shusang; Marco Senzolo; Keith Ro πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 139 KB πŸ‘ 1 views

The Model for End-Stage Liver Disease (MELD) score is now used for allocation in liver transplantation (LT) waiting lists, replacing the Child-Turcotte-Pugh (CTP) score. However, there is debate as whether it is superior to CTP score to predict mortality in patients with cirrhosis on the LT waiting

Living donor liver transplantation of th
Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center
✍ Sven Jonas; Jens Mittler; Andreas Pascher; Guido Schumacher; Tom Theruvath; Chri πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 220 KB πŸ‘ 2 views

Living donor liver transplantation of the right lobe might offer the possibility to extend the eligibility criteria of patients with hepatocellular carcinoma (HCC) in cirrhosis without penalizing patients who are waiting for a graft from a deceased donor. From 1988 to 2005, surgical treatment of HCC